Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Hisse Senetlerindeki Sıralama #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Hisse Fiyatı
$1.89
Son senkronizasyon: 2022-12-16
Piyasa Değeri
$24.38M
Değişim (1 gün)
8.62%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Yumanity Therapeutics, Inc. (YMTX)

Kategori

Yumanity Therapeutics, Inc. (YMTX) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.94 - 2022-12-01

Gün sonu en düşük fiyat: $18.35 - 2020-12-01
Yumanity Therapeutics, Inc. için hisse fiyatı geçmişi: 2020 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2022 -41.89%
2021 -81.82%
2020 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$551.16 41.05%
US
$163.88 487.17%
US
$1.03K 57.08%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH